Cic edizioni internazionali
Functional Neurology

Add-on perampanel and aggressive behaviour in severe drug-resistant focal epilepsies

Article, 215 - 220
doi: 10.11138/FNeur/2017.32.4.215
Tag this article
Abstract
Enhanced HTML Full text PDF
This study aimed to investigate the incidence of aggressiveness in patients with severe drug-refractory focal epilepsy (DRE) who started perampanel (PER) as add-on treatment, and to identify possible predisposing factors.
Data on 49 consecutive patients with severe DRE who initiated PER were retrospectively collected. Twelve of the 49 patients experienced aggressiveness as adverse event related to PER treatment, one third of them on low (2-4 mg/day) PER dosages.
PER was discontinued in 10/12 patients because of aggressive behaviors. Aggressiveness could appear after several months or even more than one year of PER treatment. One third of patients with PER-related aggressiveness had intellectual disabilities and 5/12 patients took levetiracetam as a concomitant antiepileptic drug.
Our study suggests that the occurrence of aggressive behaviors in patients with severe DRE is not uncommon during PER treatment and that it may occur after months or even years of treatment with a stable dosage, requiring PER discontinuation in the great majority of patients.

Vol. XXXIII (No. 1) 2018 January/March

  1. Mechanical thrombectomy for acute ischemic stroke: the therapeutic window is larger but still “time is brain»
    Zivelonghi C., Tamburin S.
    doi: 10.11138/FNeur/2018.33.1.005
  2. Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal
    Ferrari A., Manca M., Tugnoli V., Alberto L.
    doi: 10.11138/FNeur/2018.33.1.007
  3. Multicentre registry of brain-injured patients with disorder of consciousness: rationale and preliminary data
    Pascarella A., Fiorenza S., Masotta O., Tibollo V., Vella D., Nardone A. M., Rossi M., Volanti P., Madonia F., Castronovo G., De Cicco D., Guarnaschelli C., Achilli M.P., Chiapparino C., Angelillo M.T., Tommasi M.A., Pisano F., Grioni G., Vezzadini G., Ferriero G., Salvaderi S., Bellazzi R., Estraneo A.
    doi: 10.11138/FNeur/2018.33.1.019
  4. Apathy in Parkinson’s disease: differences between caregiver’s report and self-evaluation
    Valentino V., Iavarone A., Amboni M., Moschiano F., Picillo M., Petretta V., Cicarelli G.
    doi: 10.11138/FNeur/2018.33.1.031
  5. Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey
    Sandrini G., Baricich A., Cisari C., Paolucci S., Smania N., Picelli A.
    doi: 10.11138/FNeur/2018.33.1.037
  6. A role for accelerometry in the differential diagnosis of tremor syndromes
    Bove F., Di Lazzaro G., Mulas D., Cocciolillo F., Di Giuda D., Bentivoglio A.R.
    doi: 10.11138/FNeur/2018.33.1.045
  7. Effectiveness of a digital platform for sharing knowledge on headache management: a two-year experience
    Raieli V., Correnti E., Sandullo A., Romano M., Marchese F., Loiacono C., Brighina F.
    doi: 10.11138/FNeur/2018.33.1.051
  8. If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences
    Rossi P., Little P., De La Torre E.R., Palmaro A.
    doi: 10.11138/FNeur/2018.33.1.057
Last Viewed articles: la lista degli ultimi x visitati.
  1. Add-on perampanel and aggressive behaviour in severe drug-resistant focal epilepsies
    Juhl S., Rubboli G.
    doi: 10.11138/FNeur/2017.32.4.215
credits